Stonebridge Capital Advisors LLC Zoetis Inc. Transaction History

Stonebridge Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	BUY	$160.94 - $186.23 $8,047 - $9,311	50 Added 100.0%	100 $17,000
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $3,540 - $4,251	-27 Reduced 35.06%	50 $7,000
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $1,038 - $1,277	7 Added 10.0%	77 $11,000
Q2 2021 Aug 20, 2021	BUY	$155.9 - $187.99 $3,118 - $3,759	20 Added 40.0%	70 $13,000
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $7,200 - $8,469	50 New	50 $8,000
Q3 2020 Nov 18, 2020	SELL	$137.1 - $165.37 $6,855 - $8,268	-50 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$111.92 - $142.53 $2,798 - $3,563	-25 Reduced 33.33%	50 $7,000
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $8,137 - $9,327	-70 Reduced 48.28%	75 $10,000
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $5,628 - $6,421	50 Added 52.63%	145 $18,000
Q2 2019 Aug 15, 2019	BUY	$97.98 - $114.28 $9,308 - $10,856	95 New	95 $11,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.